Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2026-02-17
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$2.0bn
reported value
+13.9% vs Q3 2025
27positions
73.7%in top 10
1 new
7 added
4 reduced
7 sold out
vs Q3 2025
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $641.1m31.67% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $125.7m6.21% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $120.8m5.97% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $120.7m5.96% | Added +1.0m |
| KALVISTA PHARMACEUTICALS INC KALV | $108.7m5.37% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $88.8m4.39% | Reduced -5.8m |
| SAVARA INC SVRA | $82.9m4.09% | Added +1.1m |
| COGENT BIOSCIENCES INC COGT | $71.0m3.51% | Reduced -2.0m |
| ERASCA INC ERAS | $66.4m3.28% | Unchanged |
| CYTOMX THERAPEUTICS INC CTMX | $66.3m3.27% | Unchanged |
| MAZE THERAPEUTICS INC MAZE | $64.2m3.17% | Added +317.8k |
| JADE BIOSCIENCES INC JBIO | $49.7m2.45% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $49.7m2.45% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $46.4m2.29% | Reduced -920.7k |
| ENGENE HOLDINGS INC COM | $43.1m2.13% | Reduced -275.0k |
| DYNE THERAPEUTICS INC DYN | $42.5m2.10% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $41.2m2.04% | Added +39.2k |
| UPSTREAM BIO INC UPB | $31.7m1.57% | Unchanged |
| CYBIN INC COM NEW | $31.4m1.55% | New |
| ZURA BIO LTD ZURA | $28.0m1.38% | Added +713.9k |
| VOR BIOPHARMA INC VOR | $25.4m1.26% | Added +1.4m |
| CRESCENT BIOPHARMA INC. CBIO | $25.3m1.25% | Added +745.7k |
| SEPTERNA INC SEPN | $17.0m0.84% | Unchanged |
| SURROZEN INC SRZN | $14.3m0.71% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $14.3m0.71% | Unchanged |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $6.9m0.34% | Unchanged |
| CASI PHARMACEUTICALS INC CASIF | $839.2k0.04% | Unchanged |
Sold out since Q3 2025
| Security | Value then |
|---|---|
| METSERA INC | $196.3m3.8m shares |
| CIDARA THERAPEUTICS INC CDTX | $90.7m946.8k shares |
| ABIVAX SA ABVX | $49.0m576.7k shares |
| ASTRIA THERAPEUTICS INC CATB | $17.9m2.5m shares |
| PHARVARIS N V PHVS | $16.8m674.6k shares |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $8.0m750.0k shares |
| TENAX THERAPEUTICS INC TENX | $3.3m437.7k shares |